Review of nemonoxacin with special focus on clinical development

Nemonoxacin is a novel C-8-methoxy nonfluorinated quinolone with remarkably enhanced in vitro activity against a wide variety of clinically relevant pathogens, especially gram-positive bacteria, including multidrug-resistant Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Xiaohua, Huang, Haihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094567/
https://www.ncbi.nlm.nih.gov/pubmed/25045247
http://dx.doi.org/10.2147/DDDT.S63581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094567/
https://www.ncbi.nlm.nih.gov/pubmed/25045247
http://dx.doi.org/10.2147/DDDT.S63581

Ejemplares similares